Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite.
Lacking suitable alternatives, the control of malaria increasingly depends upon Artemisinin Combination Treatments (ACT): resistance to these drugs would therefore be disastrous. For ACTs, the biology of resistance to the individual components has been investigated, but experimentally induced resist...
Main Authors: | Louise A Rodrigues, Gisela Henriques, Sofia T Borges, Paul Hunt, Cecília P Sanchez, Axel Martinelli, Pedro Cravo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-07-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2904698?pdf=render |
Similar Items
-
Identification of genetic markers of resistance to Artemisinin Combination Therapy in the rodent model <it>Plasmodium chabaudi</it>
by: Cravo Pedro, et al.
Published: (2010-10-01) -
Experimental evolution, genetic analysis and genome re-sequencing reveal the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites
by: Hunt Paul, et al.
Published: (2010-09-01) -
Molecular evolution and phylogenetics of rodent malaria parasites
by: Ramiro Ricardo S, et al.
Published: (2012-11-01) -
Resistance to Artesunate + Mefloquine does not incurin fitness cost in malaria parasites
by: Cravo Pedro, et al.
Published: (2010-10-01) -
Phenotypic approach artemisinin resistance in malaria rodent as in vivo model
by: Lilik Maslachah, et al.
Published: (2017-07-01)